News
Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.
The discovery broadens the known spectrum of this rare disorder, emphasizing the critical role of collaboration with patient ...
A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.
3d
Clinical Trials Arena on MSNAkeso and Summit notch another Phase III win with their Keytruda competitorAkeso Pharmaceuticals and Summit Therapeutics have reported that their PD-1/VEGF bispecific antibody has met the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results